IRIS
ORIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.743
EU - Europa 7.460
AS - Asia 2.721
Continente sconosciuto - Info sul continente non disponibili 62
OC - Oceania 21
SA - Sud America 9
AF - Africa 7
Totale 30.023
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.718
UA - Ucraina 2.795
VN - Vietnam 1.476
GB - Regno Unito 1.158
SE - Svezia 1.106
DE - Germania 896
CN - Cina 715
FR - Francia 556
IT - Italia 388
SG - Singapore 359
FI - Finlandia 276
KR - Corea 126
PL - Polonia 109
EU - Europa 62
RU - Federazione Russa 38
NL - Olanda 29
BE - Belgio 25
AU - Australia 17
CA - Canada 16
IE - Irlanda 16
IN - India 11
DK - Danimarca 9
CZ - Repubblica Ceca 6
AT - Austria 5
BG - Bulgaria 5
ES - Italia 5
HR - Croazia 5
JP - Giappone 5
BR - Brasile 4
EG - Egitto 4
HU - Ungheria 4
IL - Israele 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
TR - Turchia 4
LU - Lussemburgo 3
MM - Myanmar 3
NO - Norvegia 3
RO - Romania 3
RS - Serbia 3
TW - Taiwan 3
BN - Brunei Darussalam 2
EE - Estonia 2
HK - Hong Kong 2
IM - Isola di Man 2
ME - Montenegro 2
MX - Messico 2
PE - Perù 2
TN - Tunisia 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
GL - Groenlandia 1
GR - Grecia 1
ID - Indonesia 1
IR - Iran 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
MC - Monaco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TC - Turks e Caicos 1
Totale 30.023
Salva come PNG Salva come JPEG
Città #
Fairfield 2.739
Woodbridge 2.587
Houston 1.969
Dong Ket 1.474
Ann Arbor 1.448
Chandler 1.364
Ashburn 1.327
Wilmington 1.310
Seattle 1.081
Cambridge 933
Dearborn 890
Jacksonville 774
Southend 630
Nyköping 614
Boardman 472
Beijing 303
Lawrence 258
Princeton 258
Singapore 219
Ogden 178
Düsseldorf 123
Des Moines 113
Kraków 108
San Diego 88
Bremen 74
Grafing 66
Nanjing 62
Jinan 55
Los Angeles 55
London 48
Hefei 40
Dallas 36
Edinburgh 28
Norwalk 27
Shenyang 27
Brussels 25
New York 25
Kunming 24
San Mateo 24
Helsinki 22
Napoli 21
Nanchang 20
Auburn Hills 18
Amsterdam 17
Hanover 17
Guangzhou 16
Mirabella Eclano 16
Rome 16
Zhengzhou 16
Taiyuan 15
Kilburn 14
Hangzhou 13
Hebei 13
Saint Petersburg 12
Dublin 11
Falls Church 11
Tianjin 11
Acton 10
Changsha 10
Hounslow 10
Montemiletto 10
Copenhagen 9
Fuzhou 9
Munich 9
Seongnam-si 9
Chicago 8
Matawan 8
Ningbo 8
Seo-gu 8
Islington 7
Milan 7
Naples 7
Nürnberg 7
Wandsworth 7
Avellino 6
Dongjak-gu 6
Miami 6
Redwood City 6
Salerno 6
San Jose 6
Frankfurt am Main 5
Haikou 5
Lanzhou 5
New Bedfont 5
Ottawa 5
Phoenix 5
Sofia 5
Stockholm 5
Sydney 5
Taizhou 5
Vienna 5
Xian 5
Zagreb 5
Brisbane 4
Budapest 4
Chieti 4
Florence 4
Groningen 4
Istanbul 4
Lisbon 4
Totale 22.427
Salva come PNG Salva come JPEG
Nome #
Il microinfusore: quali indicazioni e quando iniziare 416
Sussidio didattico per gli studenti di igiene generale e applicata per il corso di laurea in scienze del servizio sociale 257
The good and bad effects of statins on insulin sensitivity and secretion 212
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity 197
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. 196
Secrezioni ormonali ectopiche 191
Cardiopulmonary impairment in young women with polycystic ovary syndrome. 182
Cardiological aspects of growth hormone and insulin-like growth factor-I. 177
Effects of physical exercise on the female reproductive system. 175
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 171
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. 171
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. 170
Effects of neridronate treatment in elderly women with osteoporosis 164
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 164
Height, weight, height velocity of primary school population sample in Campania region. 163
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 162
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept. 162
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 160
Endocrine secretions under abnormal light-dark cycles and in the blind. 158
Failure of long-term therapy with sodium valproate in Cushing's disease. 158
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. 157
THE IMPACT OF PROBAND GLUCOSE TOLERANCE STATUS ON BODY MASS INDEX (BMI) AND ADIPOSITY IN ADOLESCENT GIRLS AT HIGH RISK FOR POLYCYSTIC OVARY SYNDROME (PCOS) 156
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood and quality of life 154
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women. 154
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 154
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review 154
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. 154
Bisphenol A in Polycystic Ovary Syndrome and its Association with Liver-Spleen Axis. 153
The increase of leukocytes as a new putative marker of low- grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome 152
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome 152
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. 152
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 152
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 151
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. 151
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 151
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. 150
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 150
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. 149
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 148
Growth hormone status in morbidly obese subjects and correlation with body composition 148
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005 148
Circulating ghrelin concentrations in the polycystic ovary syndrome 148
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. 148
Lifestyle changes in the management of adulthood and childhood obesity. 148
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 147
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. 147
Prevalence of polycystic ovary morphology in a region of South Italy. 147
Current evidence on vitamin D deficiency and kidney transplant: What’s new? 147
Ovulation induction in polycystic ovary syndrome 146
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. 146
Antisperm antibodies in cryptorchidism before and after surgery. 146
Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females 146
Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age 145
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. 145
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. 145
Effect of growth hormone on cardiac function. 143
Auditory brainstem responses in thyroid diseases before and after therapy. 143
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors 143
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women 143
Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome? 143
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 143
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. 142
Is the ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? 141
Terapia di associazione con insulina ed analoghi del GLP-1 141
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin 140
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis 140
Lymphocyte subset pattern in acromegaly. 140
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study 140
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 139
Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study 138
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS) 138
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS 138
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 138
Vitamin D and thyroid disease: to D or not to D? 138
Cardiovascular risk of women with polycystic ovary syndrome 138
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 137
Letter to the Editor: Vitamin D: A Wonder Drug for the Cure of Type 2 Diabetes? 137
Adrenal mass: insight into pathogenesis and a common link with insulin resistance. 137
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women 135
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 135
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. 135
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 135
Thyroid function and morphology after a successful kidney transplantation 135
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 135
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response 135
Anti-proliferative and pro-apoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women 134
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. 134
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 134
Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. 134
Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of Diabetes Mellitus and Pancreatic Cancer. 134
Low serum vitamin D-status, air pollution and obesity: A dangerous liaison. 134
Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis 134
Does raloxifene inhibit the growth of uterine fibroids? 133
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance 133
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 133
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome. 133
Gut: a key player in the pathogenesis of type 2 diabetes? 133
Evidence for altered adipocyte function in polycystic ovary syndrome. 132
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 132
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. 131
Totale 15.210
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.071 0 0 631 1.933 908 786 1.035 606 564 136 424 48
2020/20214.882 395 96 438 184 618 96 525 37 124 440 129 1.800
2021/20222.163 139 314 34 771 76 45 253 199 141 116 69 6
2022/20234.290 523 136 215 458 498 796 115 566 571 120 223 69
2023/20241.231 134 71 77 54 54 34 25 316 268 56 12 130
2024/2025591 86 505 0 0 0 0 0 0 0 0 0 0
Totale 30.451